Notice: Users may be experiencing issues with displaying some pages on stanfordhealthcare.org. We are working closely with our technical teams to resolve the issue as quickly as possible. Thank you for your patience.
FIVE YEARS OF FOLLOW-UP FROM THE PHASE 3 RESONATE-2 STUDY AND NURSING EXPERIENCE WITH PATIENTS RECEIVING FIRST-LINE IBRUTINIB FOR CHRONIC LYMPHOCYTIC LEUKEMIA Greenberg, E. M., Settlemire, M., Lal, I., Amaya-Chanaga, C., Coutre, S., Burger, J. A. ONCOLOGY NURSING SOC. 2020
View details for Web of Science ID 000569150400300